Presurgical maggot debridement of soft tissue wounds is associated with decreased rates of postoperative infection

Clinical Infectious Diseases

Volumn 39, Issue 7, 2004, Pages 1067-1070

  Sherman, Ronald A ^a,b   Shimoda, Kathleen J ^c  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b BioTherapeut Educ/Res Found   (United States)

^c VA LONG BEACH HEALTHCARE SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONSERVATIVE TREATMENT; CONTROLLED STUDY; DEBRIDEMENT; DISINFECTION; FLY; HUMAN; LARVA; MAGGOT; MAGGOT DEBRIDEMENT THERAPY; PHAENICIA SERICATA; POSTOPERATIVE INFECTION; PREOPERATIVE CARE; PRIORITY JOURNAL; SOFT TISSUE INJURY; WOUND CARE;

ADULT; AGED; AGED, 80 AND OVER; ANIMALS; DEBRIDEMENT; DIPTERA; FEMALE; HUMANS; LARVA; MALE; MIDDLE AGED; SURGICAL WOUND INFECTION; WOUND HEALING;

EID: 4744374038     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/423806     Document Type: Article

References (31)

1. Baer WS. The treatment of chronic osteomyelitis with the maggot (larva of the blow fly). J Bone Joint Surg 1931; 13:438-75.
2. Vistnes L, Lee R, Ksander A. Proteolytic activity of blowfly larvae secretions in experimental burns. Surgery 1981; 90:835-41.
3. Robinson W. The role of surgical maggots in the disinfection of osteomyelitis and other infected wounds. J Bone Joint Surg 1933; 15:409-12.
4. Wolff H, Hansson C. Larval therapy for a leg ulcer with methicillin-resistant Staphylococcus aureus. Acta Derm Venereol 1999; 79:320-1.
5. Mumcuoglu KY, Miller J, Mumcuoglu M, Friger M, Tarshis M. Destruction of bacteria in the digestive tract of the maggot of Lucilia sericata (Diptera: Calliphoridae). J Med Entomol 2001; 38:161-6.
6. Prete PE. Growth effects of Phaenicia sericata larval extracts on fibroblasts: mechanism for wound healing by maggot therapy. Life Sci 1997; 60:505-10.
7. Sherman RA, Hall MJR, Thomas S. Medicinal maggots: an ancient remedy for some contemporary afflictions. Annu Rev Entomol 2000; 45:55-81.
8. Robinson W. Progress of maggot therapy in the United States and Canada in the treatment of suppurative diseases. Am J Surg 1935; 29:67-71.
9. Sherman RA. Maggot therapy: the last five years. European Tissue Repair Society Bulletin 2000; 7:97-8.
10. Fleischmann W, Russ M, Moch D, Marquardt C. Biosurgery-maggots, are they really the better surgeons? [in German] Chirurg 1999; 70:1340.
11. Mumcuoglu KY, Ingber A, Gilead L, et al. Maggot therapy for the treatment of intractable wounds. Int J Dermatol 1999; 38:623-7.
12. Thomas S, Andrews A, Jones M, Church J. Maggots are useful in treating infected or necrotic wounds. BMJ 1999; 318:807-8.
13. Graninger M, Grassberger M, Galehr E, et al. Comments, opinions, and brief case reports: biosurgical debridement facilitates healing of chronic skin ulcers. Arch Intern Med 2002; 162:1906-7.
14. Jukema GN, Menon AG, Bernards AT, Steenvoorde P, Taheri Rastegar A, van Dissel JT. Amputation-sparing treatment by nature: "surgical" maggots revisited. Clin Infect Dis 2002; 35:1566-71.
15. Sherman RA, Tran J, Sullivan R. Maggot therapy for venous stasis ulcers. Arch Dermatol 1996; 132:254-6.
16. Sherman RA. A new dressing design for use with maggot therapy. Plast Reconstr Surg 1997; 100:451-6.
17. Owens WD, Felts JA, Spitznagel E Jr. ASA physical status classifications: a study of consistency of ratings. Anesthesiology 1978; 49:239-43.
18. Weil GC, Simon RJ, Sweadner WR. A biological, bacteriological and clinical study of larval or maggot therapy in the treatment of acute and chronic pyogenic infections. Am J Surg 1933; 19:36-48.
19. Nuesch R, Rahm G, Rudin W, et al. Clustering of bloodstream infections during maggot debridement therapy using contaminated larvae of Protophormia terraenovae. Infection 2002; 30:306-9.
20. Culver DH, Horan TC, Gaynes RP, et al. Surgical wound infection rates by wound class, operative procedure and patient risk index. Am J Med 1991; 91:152S-7S.
21. Garibaldi RA, Cushing D, Lerer T. Risk factors for postoperative infection. Am J Med 1991; 91:158S-63S.
22. Robinson W, Norwood VH. Destruction of pyogenic bacteria in the alimentary tract of surgical maggots implanted in infected wounds. J Lab Clin Med 1934; 19:581-6.
23. Greenberg B. Model for destruction of bacteria in the midgut of blow fly maggots. J Med Entomol 1968; 5:31-8.
24. Simmons SW. A bactericidal principle in excretions of surgical maggots which destroys important etiological agents of pyogenic infections. J Bacteriol 1935; 30:253-67.
25. Pavillard ER, Wright EA. An antibiotic from maggots. Nature 1957; 180:916-7.
26. Erdmann GR, Khalil SKW. Isolation and identification of two antibacterial agents produced by a strain of Proteus mirabilis isolated from larvae of the screwworm (Cochliomyia hominivorax) (Diptera: Calliphoridae). J Med Entomol 1986; 23:208-11.
27. Mumcuoglu KY, Miller J, Ioffe-Uspensky I, Barak V. The potential of maggots to secrete cytokines in vitro. In: Program and abstracts of the Fifth International Conference on Biotherapy (Wurzburg, Germany). 2000.
28. Wollina U, Liebold K, Schmidt WD, Hartmann M, Fassler D. Biosurgery supports granulation and debridement in chronic wounds-clinical data and remittance spectroscopy measurement. Int J Dermatol 2002; 41:635-9.
29. Sherman RA, Wyle FA, Vulpe M. Maggot debridement therapy for treating pressure ulcers in spinal cord injury patients. J Spinal Cord Med 1995; 18:71-4.
30. Wayman J, Nirojogi V, Walker A, Sowinski A, Walker MA. The cost effectiveness of larval therapy in venous ulcers. J Tissue Viability 2000; 10:91-4.
31. Sherman RA. Maggot therapy for foot and leg wounds. International Journal of Lower Extremity Wounds 2002; 1:135-42.